Moore Capital Management’s Medicines Co MDCO Stock Holding History

Moore Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100,000	Closed	-$8.49M	–	306
2019 Q4	$8.49M	Buy	+100,000	New	+$6.67M	0.28%	97
2017 Q2	–	Sell	-10,000	Closed	-$489K	–	260
2017 Q1	$489K	Buy	+10,000	New	+$456K	0.01%	183

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Moore Capital Management's MDCO Position: Q1 2020 in Review

Moore Capital Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 100,000 shares — an estimated $8.49M sold.

Moore Capital Management first reported a position in MDCO in Q1 2017 and held it in 2 quarters. The position peaked at $8.49M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Moore Capital Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Moore Capital Management sold 100,000 Medicines Co shares in Q1 2020, an estimated $8.49M.
Moore Capital Management first reported a position in Medicines Co in Q1 2017 and held it in 2 quarters.
Moore Capital Management's Medicines Co position peaked at $8.49M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Moore Capital Management's 13F filing for Q1 2020, filed 15 May 2020.